Lobbying client

AMAG PHARMACEUTICAL

Pharmaceutical Company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
45
Filed by
2
Reported in-house
—
Reported by firms
$2,075,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2017 to 2022

Filings

45 filings, newest first.
Filing Filed by Amount
3rd Quarter - Report
3rd Quarter 2021
SIMS STRATEGIES, LLC $80,000 reported
3rd Quarter - Report
3rd Quarter 2021
TREMONT STRATEGIES GROUP LLC $75,000 reported
2nd Quarter - Report
2nd Quarter 2021
TREMONT STRATEGIES GROUP LLC $75,000 reported
2nd Quarter - Report
2nd Quarter 2021
SIMS STRATEGIES, LLC $80,000 reported
1st Quarter - Report
1st Quarter 2021
TREMONT STRATEGIES GROUP LLC $75,000 reported
1st Quarter - Report
1st Quarter 2021
SIMS STRATEGIES, LLC $80,000 reported
4th Quarter - Amendment
4th Quarter 2020
TREMONT STRATEGIES GROUP LLC $40,000 reported
4th Quarter - Report
4th Quarter 2020
SIMS STRATEGIES, LLC $80,000 reported
4th Quarter - Reportreplaced
4th Quarter 2020
TREMONT STRATEGIES GROUP LLC $40,000 reported
3rd Quarter - Report
3rd Quarter 2020
SIMS STRATEGIES, LLC $80,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
SIMS STRATEGIES, LLC 22 $1,110,000
TREMONT STRATEGIES GROUP LLC 20 $965,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Pharmacy PHA 26
Health Issues HCR 21
Medicare/Medicaid MMM 5

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.